| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |